{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:43:13Z","timestamp":1790739793324,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Union's Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]}],"content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.euroneuro.2013.04.013","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T03:29:57Z","timestamp":1369193397000},"page":"657-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Developments in the field of antidepressants, where do we go now?"],"prefix":"10.1016","volume":"25","author":[{"given":"Francesc","family":"Artigas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.04.013_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0028-3908(97)00048-8","article-title":"Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas","volume":"36","author":"Adell","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cercor\/bhg128","article-title":"Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex","volume":"14","author":"Amargos-Bosch","year":"2004","journal-title":"Cereb. Cortex"},{"issue":"1","key":"10.1016\/j.euroneuro.2013.04.013_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2005.01202.x","article-title":"Cost of disorders of the brain in Europe","volume":"12","author":"Andlin-Sobocki","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0165-6147(93)90125-4","article-title":"5-HT and antidepressants: new views from microdialysis studies","volume":"14","author":"Artigas","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2012.09.006","article-title":"Serotonin receptors involved in antidepressant effects","volume":"137","author":"Artigas","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0165-6147(00)01682-5","article-title":"How does pindolol improve antidepressant action?","volume":"22","author":"Artigas","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archpsyc.1994.03950030084009","article-title":"Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors","volume":"51","author":"Artigas","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0166-2236(96)10037-0","article-title":"Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists","volume":"19","author":"Artigas","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0327(02)00404-4","article-title":"Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials","volume":"79","author":"Ballesteros","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4088\/JCP.v65n0714","article-title":"The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder","volume":"65","author":"Barbee","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.npp.1301462","article-title":"Association of the COMT val158met variant with antidepressant treatment response in major depression","volume":"33","author":"Baune","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib12","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199905133401905","article-title":"Transient acute depression induced by high-frequency deep-brain stimulation","volume":"340","author":"Bejjani","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1471-4159.1996.67020669.x","article-title":"Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats","volume":"67","author":"Bel","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.euroneuro.2006.03.002","article-title":"Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests","volume":"17","author":"Belozertseva","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.v68n0604","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study","volume":"68","author":"Berman","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.mp.4001401","article-title":"Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635","volume":"9","author":"Bhagwagar","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng1479","article-title":"Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment","volume":"36","author":"Binder","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00004714-199506000-00011","article-title":"Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression","volume":"15","author":"Blier","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.parkreldis.2007.04.005","article-title":"Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report","volume":"14","author":"Blomstedt","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib23","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.107.119404","article-title":"Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents","volume":"321","author":"Bonaventure","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib24","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mp.2011.92","article-title":"Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects","volume":"17","author":"Bortolozzi","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pbb.2011.11.006","article-title":"The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling","volume":"101","author":"Bradley","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0166-2236(00)01626-X","article-title":"Negative symptoms: the \u2018pathology\u2019 of motivation and goal-directed behaviour","volume":"23","author":"Brown","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/YCO.0b013e32831be9ef","article-title":"Augmentation strategies for treatment-resistant depression","volume":"22","author":"Carvalho","year":"2009","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF00166940","article-title":"Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat","volume":"347","author":"Celada","year":"1993","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib29","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1523\/JNEUROSCI.21-24-09917.2001","article-title":"Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors","volume":"21","author":"Celada","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib30","first-page":"541","article-title":"Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system","volume":"33","author":"Chenu","year":"2008","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib31","first-page":"453","article-title":"A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders","volume":"1","author":"Collier","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib303","doi-asserted-by":"crossref","unstructured":"Connolly, K.R., Thase, M.E., 2012. Emerging drugs for major depressive disorder. Expert Opin Emerg Drugs. 17, 105-126","DOI":"10.1517\/14728214.2012.660146"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib32","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1460-9568.2006.04943.x","article-title":"Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse","volume":"24","author":"Conductier","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib33","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.npp.1300474","article-title":"Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade","volume":"29","author":"Cremers","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib34","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-3565(24)39013-5","article-title":"Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors","volume":"295","author":"Cryan","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib35","doi-asserted-by":"crossref","unstructured":"Danish University Antidepressant Group, 1986. Citalopram: Clinical Effect Profile in Comparison with Clomipramine. A Controlled Multicenter Study. Psychopharmacology (Berlin) 90, 131-138.","DOI":"10.1007\/BF00172884"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib36","doi-asserted-by":"crossref","unstructured":"Danish University Antidepressant Group, 1990. Paroxetine: A Selective Serotonin Reuptake Inhibitor Showing Better Tolerance, but Weaker Antidepressant Effect than Clomipramine in a Controlled Multicenter Study. Journal of Affective Disorders, vol. 18, pp. 289\u2013299.","DOI":"10.1016\/0165-0327(90)90081-I"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib37","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.neuroscience.2007.04.045","article-title":"Acute onset by 5-HT(6)-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression","volume":"147","author":"de Foubert","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archpsyc.1990.01810170011002","article-title":"Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan","volume":"47","author":"Delgado","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib39","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.euroneuro.2010.04.005","article-title":"F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists","volume":"20","author":"Depoortere","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/mp.2011.159","article-title":"5-HT(2B) receptors are required for serotonin-selective antidepressant actions","volume":"17","author":"Diaz","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0006-3223(99)00189-4","article-title":"PET imaging of serotonin 1A receptor binding in depression","volume":"46","author":"Drevets","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00429-008-0189-x","article-title":"Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression","volume":"213","author":"Drevets","year":"2008","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","author":"Duman","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib44","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1461145711001702","article-title":"mTOR activation is required for the antidepressant effects of mGluR(2)\/(3) blockade","volume":"15","author":"Dwyer","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib46","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.mp.4001314","article-title":"Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor","volume":"8","author":"Eisensamer","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0306-4522(94)90384-0","article-title":"Facilitation of 5-hydroxytryptamine3 receptor desensitization by fluoxetine","volume":"62","author":"Fan","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-012-2795-9","article-title":"Acute 5-HT(1)A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions","volume":"225","author":"Ferres-Coy","year":"2013","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cne.20738","article-title":"Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers","volume":"492","author":"Gabbott","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib50","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1046\/j.1471-4159.1997.68031159.x","article-title":"Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935","volume":"68","author":"Gobert","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(00)26003-2","article-title":"The prefrontal cortex and the integration of sensory, limbic and autonomic information","volume":"126","author":"Groenewegen","year":"2000","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0896-6273(02)00660-8","article-title":"Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims","volume":"34","author":"Gurevich","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib53","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","article-title":"Cost of disorders of the brain in Europe 2010","volume":"21","author":"Gustavsson","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib54","doi-asserted-by":"crossref","first-page":"10150","DOI":"10.1523\/JNEUROSCI.18-23-10150.1998","article-title":"Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors","volume":"18","author":"Haddjeri","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0306-4522(98)00157-2","article-title":"An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat","volume":"87","author":"Hajos","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biopsych.2009.08.025","article-title":"Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats","volume":"67","author":"Hamani","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-0173(01)00082-0","article-title":"Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus","volume":"38","author":"Harro","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib58","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-009-1626-0","article-title":"The 5-HT7 receptor and disorders of the nervous system: an overview","volume":"206","author":"Hedlund","year":"2009","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib59","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2004.07.002","article-title":"Functional, molecular and pharmacological advances in 5-HT7 receptor research","volume":"25","author":"Hedlund","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.bjp.0703297","article-title":"Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat","volume":"130","author":"Hervas","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib61","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2003.09.011","article-title":"Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders","volume":"24","author":"Holmes","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archgenpsychiatry.2011.1456","article-title":"Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression","volume":"69","author":"Holtzheimer","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib63","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib64","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/sj.npp.1301646","article-title":"N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity","volume":"33","author":"Jensen","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0306-4522(97)00372-2","article-title":"Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons","volume":"83","author":"Jodo","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib66","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archpsyc.63.12.1337","article-title":"Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE)","volume":"63","author":"Kellner","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.euroneuro.2005.09.002","article-title":"Placebo-controlled trial of agomelatine in the treatment of major depressive disorder","volume":"16","author":"Kennedy","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib68","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib69","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/JCP.0b013e318218dcd5","article-title":"A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia","volume":"31","author":"Kinon","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib70","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1523\/JNEUROSCI.1656-08.2008","article-title":"Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fibre synaptic transmission","volume":"28","author":"Kobayashi","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib72","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1177\/0269881111424931","article-title":"Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials","volume":"26","author":"Learned","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib73","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1523\/JNEUROSCI.23-25-08788.2003","article-title":"Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide","volume":"23","author":"Lemonde","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib74","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib75","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/archgenpsychiatry.2009.38","article-title":"Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response","volume":"66","author":"Licinio","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib76","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1476-5381.2010.00738.x","article-title":"Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors","volume":"160","author":"Llado-Pelfort","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib77","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.neuron.2013.01.020","article-title":"Probing and regulating dysfunctional circuits using deep brain stimulation","volume":"77","author":"Lozano","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib78","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.biopsych.2004.12.023","article-title":"Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists","volume":"57","author":"Lucas","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib79","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","article-title":"Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action","volume":"55","author":"Lucas","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib80","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.npp.1300057","article-title":"Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders","volume":"28","author":"Marek","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib81","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0893-133X(00)00187-1","article-title":"Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans","volume":"24","author":"Martinez","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib82","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1523\/JNEUROSCI.21-24-09856.2001","article-title":"Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism","volume":"21","author":"Martin-Ruiz","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib83","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"Mayberg","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib84","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1073\/pnas.0508063102","article-title":"A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo","volume":"102","author":"Mitsukawa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib85","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-895X(25)13616-X","article-title":"Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs","volume":"43","author":"Monsma","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib86","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1523\/JNEUROSCI.17-09-03157.1997","article-title":"The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon","volume":"17","author":"Morales","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib87","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.111.189068","article-title":"Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder","volume":"340","author":"Mork","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib88","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/syn.20398","article-title":"Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635","volume":"61","author":"Moses-Kolko","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib89","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0893-133X(99)00041-X","article-title":"Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus","volume":"21","author":"Mullins","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib90","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990\u20132020: global burden of disease study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib91","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib92","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/mp.2008.8","article-title":"Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression","volume":"14","author":"Neff","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib94","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","article-title":"The mesolimbic dopamine reward circuit in depression","volume":"59","author":"Nestler","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib95","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0893-133X(96)00095-4","article-title":"Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus","volume":"15","author":"Neumaier","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib96","first-page":"1","article-title":"Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain","author":"Nord","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib97","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2010.02.059","article-title":"Metabotropic glutamate receptor 7: at the interface of cognition and emotion","volume":"639","author":"O'Connor","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib98","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/jpet.102.034280","article-title":"Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist","volume":"302","author":"Page","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib99","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.biopsych.2010.03.023","article-title":"Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations","volume":"68","author":"Parsey","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2005.06.016","article-title":"Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study","volume":"59","author":"Parsey","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib101","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib102","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0140-6736(96)08007-5","article-title":"Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment","volume":"349","author":"Perez","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib103","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.56.4.375","article-title":"A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius","volume":"56","author":"Perez","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib104","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/npp.2008.6","article-title":"Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study","volume":"33","author":"Perlis","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib105","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.mp.4001502","article-title":"Investigation of serotonin-related genes in antidepressant response","volume":"9","author":"Peters","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib106","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.euroneuro.2009.04.004","article-title":"Pindolol augmentation enhances response outcomes in first depressive episodes","volume":"19","author":"Portella","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib107","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4088\/JCP.09m05827blu","article-title":"Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression","volume":"72","author":"Portella","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib108","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tics.2011.12.011","article-title":"Neural circuits underlying the pathophysiology of mood disorders","volume":"16","author":"Price","year":"2012","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib109","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/cercor\/bhh097","article-title":"In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors","volume":"14","author":"Puig","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib1109","doi-asserted-by":"crossref","unstructured":"Puig, M.V., Artigas, F., Celada, P. 2005. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: Involvement of serotonin and GABA. Cereb Cortex 15, 1-14.","DOI":"10.1093\/cercor\/bhh104"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib110","first-page":"1","article-title":"Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression","author":"Puigdemont","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib111","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0893-133X(95)00240-E","article-title":"Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain","volume":"15","author":"Romero","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib112","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.npp.1300062","article-title":"Modulation of serotonergic function in rat brain by VN2222, a serotonin reuptake inhibitor and 5-HT1A receptor agonist","volume":"28","author":"Romero","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib113","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib114","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1073\/pnas.92.13.6032","article-title":"Inhibitory influence of frontal cortex on locus coeruleus neurons","volume":"92","author":"Sara","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib115","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nn1969","article-title":"Adult hippocampal neurogenesis in depression","volume":"10","author":"Sahay","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib116","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archpsyc.57.2.174","article-title":"Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment","volume":"57","author":"Sargent","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib117","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1476-5381.2011.01770.x","article-title":"Preclinical and clinical characterisation of the selective serotonin-1A receptor antagonist DU-125530 for antidepressant treatment","volume":"167","author":"Scorza","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib118","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroimage.2004.01.015","article-title":"Limbic-frontal circuitry in major depression: a path modeling metanalysis","volume":"22","author":"Seminowicz","year":"2004","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib119","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1017\/S1461145703003924","article-title":"An autoradiographic study of the influence of pindolol upon [35S]GTPgammaS binding in rat, guinea pig and human brain","volume":"7","author":"Serrats","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001926","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients","volume":"12","author":"Serretti","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib121","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1176\/appi.ajp.158.1.131","article-title":"A novel augmentation strategy for treating resistant major depression","volume":"158","author":"Shelton","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib122","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/187152707780363285","article-title":"Triple reuptake inhibitors (\u201cbroad spectrum\u201d antidepressants)","volume":"6","author":"Skolnick","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib123","first-page":"225","article-title":"Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu(4) receptor","volume":"65","author":"Slawinska","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib124","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.mp.4000425","article-title":"Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine","volume":"3","author":"Smeraldi","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib125","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.4088\/JCP.10bs06601gry","article-title":"The serotonin-7 receptor as a novel therapeutic target","volume":"71","author":"Stahl","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib126","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1523\/JNEUROSCI.18-18-07394.1998","article-title":"Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity","volume":"18","author":"Stockmeier","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib127","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-200412000-00001","article-title":"Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression","volume":"15","author":"Tatarczynska","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib1125","doi-asserted-by":"crossref","unstructured":"Thakker, D.R., Natt, F., H\u00fcsken, D., van der Putten, H., Maier, R., Hoyer, D., Cryan, J.F., 2005. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol Psychiatry 10, 782-789.","DOI":"10.1038\/sj.mp.4001687"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","article-title":"Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors","volume":"178","author":"Thase","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0893-133X(94)00058-8","article-title":"MAOIs in the contemporary treatment of depression","volume":"12","author":"Thase","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib130","first-page":"275","article-title":"Diencephalic and mesencephalic efferents of the medial prefrontal cortex in the rat: electrophysiological evidence for the existence of branched axons","volume":"50","author":"Thierry","year":"1983","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib131","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00004850-199400940-00003","article-title":"How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo","volume":"9","author":"Tollefson","year":"1994","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib132","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1098-2396(199603)22:3<195::AID-SYN1>3.0.CO;2-7","article-title":"Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events","volume":"22","author":"Tong","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib133","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpsychires.2011.09.003","article-title":"Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Tran","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib134","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2007.11.017","article-title":"Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression","volume":"57","author":"Uhr","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib137","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.neuropharm.2007.01.007","article-title":"Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression","volume":"52","author":"Wesolowska","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib138","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuropharm.2006.04.017","article-title":"Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression","volume":"51","author":"Wesolowska","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib139","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2006.10.001","article-title":"Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice","volume":"555","author":"Wesolowska","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0269881108097714","article-title":"Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review","volume":"24","author":"Whale","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib141","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/mp.2008.59","article-title":"Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response","volume":"13","author":"Wong","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib142","doi-asserted-by":"crossref","first-page":"15124","DOI":"10.1073\/pnas.0602795103","article-title":"Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response","volume":"103","author":"Wong","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib143","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1176\/appi.ajp.161.9.1575","article-title":"Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms","volume":"161","author":"Yoshida","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.04.013_bib144","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00004714-200002000-00021","article-title":"Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene","volume":"20","author":"Zanardi","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2013.04.013_bib145","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13001442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13001442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:53:40Z","timestamp":1746010420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13001442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":147,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0924977X13001442"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.04.013","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developments in the field of antidepressants, where do we go now?","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}